Your session is about to expire
← Back to Search
Multisensory Training for Hemianopia
N/A
Waitlist Available
Led By Benjamin A Rowland, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age >= 18 years old
Be older than 18 years old
Must not have
Current major medical problems that might independently affect cognition, vision, or interfere with ability to attend study visits. This includes pathology of the retina or optic nerve explanatory of blindness
Unable or unwilling to attend scheduled testing and training sessions, including the 12 month follow up
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 64
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to restore vision in stroke patients using a multi-sensory training technique and evaluate its effects on the brain.
Who is the study for?
Adults over 18 with stable homonymous hemianopia for at least 6 months, or new cases less than a month old. Participants must speak English, be cognitively normal, have reliable transportation, and be MRI compatible. Exclusions include current major medical issues affecting cognition or vision, substance abuse, other neurological disorders like dementia or Parkinson's disease.
What is being tested?
The trial is testing multisensory training to improve vision in patients with blindness caused by stroke. It compares the effectiveness of this technique on those with long-standing blindness versus those recently affected.
What are the potential side effects?
Since this study involves non-invasive training techniques rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during the exercises.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have major health issues affecting my thinking, sight, or ability to attend study visits.
Select...
I can attend all required tests, training, and follow-up sessions.
Select...
I do not have a major neurological disorder that could affect my ability to follow instructions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 64
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 64
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Clinical Ophthalmological Test Scores
Functional magnetic resonance imaging (fMRI) scans
Quality of Life (QoL) Assessment
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Standard Intervention: Multisensory TrainingExperimental Treatment1 Intervention
Patients with stable hemianopia (\>6 months) are given multisensory training
Group II: Early Intervention: Multisensory TrainingExperimental Treatment1 Intervention
Patients with early hemianopia (\<1 months) are given multisensory training
Group III: Standard Intervention: Unisensory TrainingActive Control2 Interventions
Patients with stable hemianopia (\>6 months) are given auditory training and crossover to multisensory training
Group IV: Early Intervention: Unisensory TrainingActive Control2 Interventions
Patients with early hemianopia (\<1 months) are given auditory training and crossover to multisensory training
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,403 Previous Clinical Trials
2,477,863 Total Patients Enrolled
Benjamin A Rowland, PhDPrincipal InvestigatorWake Forest University Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with vision loss on the same side of both eyes for over 6 months.A doctor has not excluded me from the study due to stroke symptoms.Can safely undergo an MRI scan.I am on medication that may not be safe with the trial treatment.You are able to do daily activities without a problem, or a recent test showed that your memory and thinking are normal.I do not have major health issues affecting my thinking, sight, or ability to attend study visits.I can attend all required tests, training, and follow-up sessions.I am 18 years old or older.I do not have a major neurological disorder that could affect my ability to follow instructions.You regularly drink more than 14 alcoholic drinks a week or use illegal drugs.
Research Study Groups:
This trial has the following groups:- Group 1: Standard Intervention: Multisensory Training
- Group 2: Standard Intervention: Unisensory Training
- Group 3: Early Intervention: Multisensory Training
- Group 4: Early Intervention: Unisensory Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.